All Stories

  1. Navigating between management of pulmonary arterial hypertension and cardiometabolic and pulmonary comorbidities
  2. Impact of preoperative body mass index on long-term survival, quality of life, and functional outcomes after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: Results from the UK National Cohort
  3. Worldwide CTEPH Registry: Long-Term Outcomes With Pulmonary Endarterectomy, Balloon Pulmonary Angioplasty, and Medical Therapy
  4. Efficacy and safety of selexipag in patients with inoperable or persistent/recurrent CTEPH (SELECT randomised trial)
  5. Pulmonary hypertension associated with lung diseases
  6. CTEPH is an uncommon complication of COVID-19: UK national surveillance and observational screening cohort studies
  7. The Digital 1-Minute Walk Test: A New Patient-centered Cardiorespiratory Endpoint
  8. Pulmonary Embolism (PE) to Chronic Thromboembolic Pulmonary Disease (CTEPD): Findings from a Survey of UK Physicians
  9. Blood DNA methylation profiling identifies cathepsin Z dysregulation in pulmonary arterial hypertension
  10. Chronic Thromboembolic Pulmonary Hypertension: A Review of the Multifaceted Pathobiology
  11. Oral Treprostinil is Associated with Improved Survival in FREEDOM-EV and its Open-Label Extension
  12. Predictors of outcomes in mild pulmonary hypertension according to 2022 ESC/ERS Guidelines: the EVIDENCE-PAH UK study
  13. European Society of Cardiology quality indicators for the care and outcomes of adults with pulmonary arterial hypertension. Developed in collaboration with the Heart Failure Association of the European Society of Cardiology
  14. Angiopoietin 2 and hsCRP are associated with pulmonary hemodynamics and long-term mortality respectively in CTEPH—Results from a prospective discovery and validation biomarker study
  15. Corrigendum to: 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respir...
  16. Right ventricular–pulmonary artery coupling in chronic thromboembolic pulmonary hypertension
  17. First Genotype–Phenotype Study in TBX4 Syndrome: Gain-of-Function Mutations Causative for Lung Disease
  18. Prevalence and clinical significance of conduction disease in patients with idiopathic pulmonary arterial hypertension
  19. Oral anticoagulants (NOAC and VKA) in chronic thromboembolic pulmonary hypertension
  20. Different Cytokine Patterns in BMPR2-Mutation-Positive Patients and Patients With Pulmonary Arterial Hypertension Without Mutations and Their Influence on Survival
  21. CAMPHOR score: patient-reported outcomes are improved by pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension